Cape Fear BioCapital
Venture capitalDurham · Pre-Seed–Series B · 3 people tracked
Investment thesis
Cape Fear BioCapital partners with founders at the seed stage to accelerate therapeutics development from validated academic research to clinical development. The firm focuses on North Carolina-based companies leveraging research from Duke, UNC, and NC State, investing in differentiated biology with novel modalities, validated mechanisms, and platforms targeting companies within three years of IND filing. The firm backs both platform companies with multi-indication potential and single-asset programs with clear paths to clinical development.
Source: firm website, verified Jul 21, 2026.
Team · 3 people
from the firm's websiteFounder, scientist, and executive with 15+ years creating and advising life sciences companies in the Research Triangle, and co-founder and former CSO of venture-backed Locus Biosciences which raised over $150M.
Senior leader with 25+ years in biotechnology, including three exits, over $200M raised, advancement of ten+ therapeutics programs to clinical development, and multiple university innovation spinouts.
Founder and leader of numerous life science enterprises in North Carolina with 30+ years of experience, including tenure as Managing Director of Carolina Research Ventures managing three side funds and over 15 early-stage investments.
Investments · 6 tracked
founders shown can be your intro pathEarly-stage oncology company developing a breakthrough siRNA platform to target undruggable cancer pathways.
Frequently asked questions
- What stage does Cape Fear BioCapital invest at?
- Cape Fear BioCapital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does Cape Fear BioCapital focus on?
- Cape Fear BioCapital focuses on Biotech, Digital Health, Medical Devices.
- Where is Cape Fear BioCapital located?
- Cape Fear BioCapital is headquartered in Durham, US.
- Does Cape Fear BioCapital lead rounds?
- Yes, Cape Fear BioCapital leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.